Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 60448 record(s)

Req # A-2021-001700

Adverse Drug Reaction (ADR) for BISACODYL. Report Number: 000958454.

Organization: Health Canada

31 page(s)
March 2022

Req # A-2021-001703

Adverse Drug Reactions (ADRs) for MMR II. Report Numbers: E2B_01928930, E2B_02063166, E2B_02073840, 000718882, E2B_02558683, E2B_02327669, E2B_02345618, E2B_01951540, E2B_01951549, 000724604.

Organization: Health Canada

159 page(s)
March 2022

Req # A-2021-001713

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075658-600.

Organization: Health Canada

9 page(s)
March 2022

Req # A-2021-001715

Adverse Drug Reactions (ADRs). Report Numbers: 000961898, 000961129, E2B_00600345.

Organization: Health Canada

24 page(s)
March 2022

Req # A-2021-001725

Adverse Drug Reaction (ADR) for TRIAMCINOLONE ACETONIDE. Report Number: E2B_04425198.

Organization: Health Canada

8 page(s)
March 2022

Req # A-2021-001731

Adverse Drug Reactions (ADRs) for INSULIN GLARGINE. Report Numbers: 000963329, 000963572.

Organization: Health Canada

12 page(s)
March 2022

Req # A-2021-001732

Adverse Drug Reactions (ADRs) for ENOXAPARIN SODIUM, GLYCERYL TRINITRATE, HYDROCORTISONE ACETATE. Report Numbers: 000955992, 000962382, 000958454, E2B_04501798, E2B_04502236, E2B_04441408, E2B_04582728, E2B_04619567.

Organization: Health Canada

335 page(s)
March 2022

Req # A-2021-001733

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report Numbers: E2B_04098503, E2B_04290556, E2B_03494956.

Organization: Health Canada

196 page(s)
March 2022

Req # A-2021-001734

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report Numbers: E2B_04202217, E2B_04209562, E2B_04326329, E2B_04325034, E2B_04325809, E2B_04336916, 000960005, 000962355, 000962438, E2B_04370585, 000964820, 000963775, 000963738, 000966465, E2B_04591222, E2B_04414476.

Organization: Health Canada

207 page(s)
March 2022

Req # A-2021-001752

Adverse Drug Reaction (ADR). Report Number: E2B_04622099.

Organization: Health Canada

94 page(s)
March 2022

What's new in open government?

Date modified: